Also like the transdermals but realistically they are still a few years off in production terms and this is without discussing intramuscular or large molecule arena.
Went out and looked at how healthcare workers were around needles first hand and anything that can be done to improve the process before the arrival of effective and wide ranging transdermals is most welcome. Not just for the primary healthcare workers but for others coming into contacts with syringes. Revenue protection is, as Kaybe rightly points out, a main motivation here and a twisted hook but every small improvement is a step in the right direction.
Looking forward to a few years from now, when all the fuss about NASDAQ listing is forgotten and the PRR share price has had it's big rise and we can ponder mechanisms to lock in profits from patents even longer, the more the merrier :)
PRR Price at posting:
31.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)